High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis

NCT ID: NCT07070557

Last Updated: 2025-07-17

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-07-15
• Study Completion Date: 2026-05-01

Brief Summary

To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.

Conditions

Hemodialysis Patient

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Interventions

neutrophil lymphocyte ratio and platelet lymphocyte ratio

explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• All cases with age ≥ 18 years from both sexes female and male, having end-stage renal disease (ESRD), who have been on hemodialysis for at least three months and divided to 4 groups according to the median of NLR and PLR

Exclusion Criteria

• • Patients aged < 18 years old.

• Patient with autoimmune disease.
• Patient with liver cirrhosis.
• Patients with immunodeficiency.
• Patients with malignancy.

• Minimum Eligible Age: 18 Months
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Sohag University

OTHER

Sponsor Role: lead

Responsible Party

Bassem Ayman Mohamed

resident in internal medicine department

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Hemodialysis Unit

Sohag, Sohag Governorate, Egypt

Countries

Egypt

Facility Contacts

ali taha, professor of internal medicine

Role: primary

alitaha23222@gmail.com

01005871047

marwa zanaty, lecture of internal medicine

Role: backup

01007100970

Other Identifiers

Soh-Med--25-6-10MS

Identifier Type: -

Identifier Source: org_study_id